KHDRBS1 and prostate carcinoma: Furthermore, the RAS pathway also stimulates Sam68-mediated splicing of the oncogenic cyclin D1b variant in prostate cancer cells [87], further pointing to Sam68 as a key effector of the splicing program activated by this pathway.